Immunic appoints Michael Panzara as CMO; prior CMO Andreas Muehler resigns, transitions to consultant

IMMUNIC, INC.

Michael Panzara appointed CMO effective April 24, 2026; base salary $600K, annual bonus target ≥50% of salary, signing bonus $125K.
Andreas Muehler resigned as CMO effective April 27, 2026; will serve as Senior Medical Officer through April 30, then consultant 10 months at $10K/month.
Panzara granted inducement option for 300K shares (post-split) vesting 50% at 1 year, 50% over 24 months thereafter.
Muehler receives 12 months base salary severance, pro-rated FY2026 bonus, full equity vesting, and 3-year post-termination exercise window.
No disagreement cited for Muehler's departure; Panzara brings >25 years neurology drug development experience including MS approvals at Biogen/Sanofi.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael A. Panzara

Chief Medical Officer

IMUX · IMMUNIC, INC.

Effective: 2026-04-24
Filed: April 28, 2026, 7:59 PM ET

Immunic, Inc. (the "Company") appointed Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael A. Panzara was appointed as Chief Medical Officer at IMMUNIC, INC..

Action: appointed
Role: Chief Medical Officer

Exact text from the filing

Immunic, Inc. (the "Company") appointed Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer of the Company, effective immediately.

View on SEC.gov

IMMUNIC, INC. filing history →

Source: SEC EDGAR

accession 0001193805-26-000516

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.